Trial Summary
What is the purpose of this trial?
This research will involve a prospective study on infection rates after grade 1 or 2 open fractures in the skeletally immature pediatric population. There will be 3 arms: one dose intravenous cefazolin, 24 hours intravenous cefazolin, and 24 hours intravenous cefazolin plus 5 days of oral cephalexin.
Research Team
SR
Sivashanmugam Raju, MD
Principal Investigator
St. Louis University
Eligibility Criteria
This trial is for children and teens (0-17 years old) with immature bones who have a mild to moderate open fracture that happened within the last day. They must be able to take cephalosporin antibiotics, not need surgery for the fracture, and speak English.Inclusion Criteria
I have a minor to moderate open fracture that occurred within the last day.
Patients under 18 years of age, as determined by radiologic imaging assessed by an orthopaedic doctor.
I am 17 years old or younger.
See 1 more
Exclusion Criteria
Allergies to cephalosporins
I am 18 years old or older.
You have a severe allergic reaction to penicillin.
See 6 more
Treatment Details
Interventions
- Cefazolin (Anti-tumor antibiotic)
- Cephalexin (Anti-tumor antibiotic)
Trial OverviewThe study compares infection rates in young patients with open fractures using different antibiotic treatments: one dose of IV cefazolin, 24 hours of IV cefazolin, or 24 hours of IV cefazolin plus 5 days oral cephalexin.
Participant Groups
3Treatment groups
Active Control
Group I: One dose of IV cefazolinActive Control1 Intervention
Patients in group A will receive one dose of IV cefazolin and will have no further antibiotic administration.
Group II: 24 hours IV cefazolinActive Control1 Intervention
Patients in group B will receive a dose of IV cefazolin every 8 hours for 24 hours (a total of 3 doses).
Group III: 24 hours IV cefazolin plus 5 days oral cephalexinActive Control2 Interventions
Patients in group C will receive a dose of IV cefazolin every 8 hours for 24 hours (a total of 3 doses). Additionally, they will be instructed to take 5 days of oral cephalexin.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Saint Louis UniversitySaint Louis, MO
Loading ...
Who Is Running the Clinical Trial?
St. Louis University
Lead Sponsor
Trials
197
Patients Recruited
41,400+